New Delhi, January 19, 2018: Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions has reported record performance in the third quarter of the Financial Year 2017-18 (Q3 FY 2017-18) as the revenue reached Rs 2,068 crore.
According to the financial result announced by the Company, the revenue went up by up 42 per cent on Year on Year (YoY) basis whereas net profit reached to Rs 213 crore, up 78 (yoy) with eps of Rs 13.
64.
The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company met today to approve financial results for the quarter and nine months ended December 31, 2017.
Commenting on the company’s performance, Shyam S Bhartia, Chairman and Hari S Bhartia, Co-Chairman & Managing Director, Jubilant Life Sciences said, “We are happy to report record growth in both revenues and profits.
United News of India
